Co-Diagnostics Debt Issuance/Retirement Net - Total 2017-2023 | CODX
Co-Diagnostics debt issuance/retirement net - total from 2017 to 2023. Debt issuance/retirement net - total can be defined as the total amount of short term and long term borrowings repaid and issued.
| Co-Diagnostics Annual Debt Issuance/Retirement Net - Total (Millions of US $) |
|
|---|---|
| 2023 | $ |
| 2022 | $ |
| 2021 | $ |
| 2020 | $ |
| 2019 | $ |
| 2018 | $ |
| 2017 | $-0 |
| 2016 | $2 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.036B | $0.007B |
| Co-Diagnostics Inc. is a molecular diagnostics company. It develops, manufactures and markets a new, state-of-the-art diagnostics technology. The Company's technology is utilized for tests which are designed using the detection and/or analysis of nucleic acid molecules. It also uses proprietary technology to design specific tests to locate genetic markers for use in industries other than infectious disease and license the use of those tests to specific customers. Co-Diagnostics Inc. is based in UT, United States. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health (ELV) | United States | $126.410B | 15.86 |
| Cencora (COR) | United States | $44.248B | 17.25 |
| ICON (ICLR) | Ireland | $26.054B | 24.60 |
| DiDi Global (DIDIY) | China | $22.390B | 0.00 |
| Avantor (AVTR) | United States | $16.968B | 24.98 |
| CochLear (CHEOY) | Australia | $14.783B | 0.00 |
| Revvity (RVTY) | United States | $13.383B | 23.48 |
| Natera (NTRA) | United States | $13.324B | 0.00 |
| Viatris (VTRS) | United States | $13.121B | 3.92 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $12.374B | 0.00 |
| Medpace Holdings (MEDP) | United States | $12.185B | 40.09 |
| Charles River Laboratories (CRL) | United States | $11.577B | 22.17 |
| Solventum (SOLV) | United States | $10.632B | 0.00 |
| Sonic Healthcare (SKHHY) | Australia | $8.628B | 0.00 |
| HealthEquity (HQY) | United States | $6.727B | 50.26 |
| Organon (OGN) | United States | $5.534B | 5.25 |
| Bausch + Lomb (BLCO) | Canada | $5.357B | 21.47 |
| Doximity (DOCS) | United States | $4.429B | 30.83 |
| PACS (PACS) | United States | $4.249B | 0.00 |
| Surgery Partners (SGRY) | United States | $3.362B | 30.76 |
| Sotera Health (SHC) | United States | $3.230B | 15.85 |
| Life Times (LTH) | United States | $3.106B | 32.54 |
| GoodRx Holdings (GDRX) | United States | $3.024B | 115.14 |
| Progyny (PGNY) | United States | $2.623B | 45.16 |
| NovoCure (NVCR) | Jersey | $2.386B | 0.00 |
| Agilon Health (AGL) | United States | $2.295B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $2.244B | 8.89 |
| Teladoc Health (TDOC) | United States | $2.188B | 0.00 |
| Premier (PINC) | United States | $2.073B | 8.87 |
| BrightSpring Health Services (BTSG) | United States | $1.953B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.595B | 0.00 | |
| Alignment Healthcare (ALHC) | United States | $1.336B | 0.00 |
| Embecta (EMBC) | United States | $0.819B | 5.57 |
| CareDx (CDNA) | United States | $0.770B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.703B | 18.40 |
| Pediatrix Medical (MD) | United States | $0.656B | 6.96 |
| Auna S.A (AUNA) | Luxembourg | $0.632B | 0.00 |
| GeneDx Holdings (WGS) | United States | $0.627B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.546B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.519B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.452B | 0.00 |
| Enhabit (EHAB) | United States | $0.419B | 41.75 |
| ModivCare (MODV) | United States | $0.396B | 7.41 |
| MultiPlan (MPLN) | United States | $0.385B | 0.00 |
| Beauty Health (SKIN) | United States | $0.342B | 0.00 |
| LifeMD (LFMD) | United States | $0.326B | 0.00 |
| DocGo (DCGO) | United States | $0.325B | 17.78 |
| Ascend Wellness Holdings (AAWH) | United States | $0.289B | 0.00 |
| Sharecare (SHCR) | United States | $0.284B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.274B | 0.00 |
| Biodesix (BDSX) | United States | $0.179B | 0.00 |
| So-Young (SY) | China | $0.123B | 41.33 |
| Pono Capital Two (PTWO) | United States | $0.068B | 0.00 |
| NeueHealth (NEUE) | United States | $0.050B | 6.80 |
| Oncology Institute (TOI) | United States | $0.050B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.047B | 0.00 |
| Nutex Health (NUTX) | United States | $0.037B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.030B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.029B | 0.00 |
| Singular Genomics Systems (OMIC) | United States | $0.027B | 0.00 |
| OncoCyte (OCX) | United States | $0.025B | 0.00 |
| Aesthetic Medical Hldngs Group (AIH) | China | $0.024B | 0.00 |
| DermTech (DMTK) | United States | $0.020B | 0.00 |
| BIMI Holdings (BIMI) | United States | $0.013B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.010B | 0.00 | |
| TRxADE HEALTH (MEDS) | United States | $0.008B | 0.00 |
| XWELL (XWEL) | United States | $0.008B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.007B | 0.00 |
| OpGen (OPGN) | United States | $0.006B | 0.00 |
| NewGenIvf Group (NIVF) | Singapore | $0.005B | 0.00 |
| Assure Holdings (IONM) | United States | $0.003B | 0.00 |
| Aclarion (ACON) | United States | $0.003B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |